Chemoinformaics analysis of Bersaldegenin-3-Acetate
Molecular Weight | 474.55 | nRot | 3 |
Heavy Atom Molecular Weight | 440.278 | nRig | 29 |
Exact Molecular Weight | 474.225 | nRing | 5 |
Solubility: LogS | -3.086 | nHRing | 1 |
Solubility: LogP | 0.587 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
nHA | 8 | APOL | 72.507 |
nHD | 3 | BPOL | 40.185 |
QED | 0.448 |
Synth | 5.055 |
Natural Product Likeliness | 2.83 |
NR-PPAR-gamma | 0.955 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.906 |
Pgp-sub | 0.502 |
HIA | 0.798 |
CACO-2 | -5.016 |
MDCK | 0.0000474 |
BBB | 0.997 |
PPB | 0.655192 |
VDSS | 0.583 |
FU | 0.30772 |
CYP1A2-inh | 0.006 |
CYP1A2-sub | 0.172 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.189 |
CYP2c9-inh | 0.017 |
CYP2c9-sub | 0.215 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.143 |
CYP3a4-inh | 0.478 |
CYP3a4-sub | 0.384 |
CL | 4.671 |
T12 | 0.079 |
hERG | 0.137 |
Ames | 0.025 |
ROA | 0.984 |
SkinSen | 0.056 |
Carcinogencity | 0.849 |
EI | 0.007 |
Respiratory | 0.718 |
NR-Aromatase | 0.838 |
Antiviral | Yes |
Prediction | 0.809857 |